Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Current Assets (2016 - 2025)

Historic Current Assets for BioCorRx (BICX) over the last 17 years, with Q3 2025 value amounting to $1.5 million.

  • BioCorRx's Current Assets rose 31410.04% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 31410.04%. This contributed to the annual value of $117996.0 for FY2024, which is 3694.07% down from last year.
  • Latest data reveals that BioCorRx reported Current Assets of $1.5 million as of Q3 2025, which was up 31410.04% from $527483.0 recorded in Q2 2025.
  • BioCorRx's 5-year Current Assets high stood at $2.0 million for Q1 2021, and its period low was $117996.0 during Q4 2024.
  • Its 5-year average for Current Assets is $536003.3, with a median of $353097.0 in 2024.
  • Its Current Assets has fluctuated over the past 5 years, first tumbled by 7658.01% in 2021, then soared by 31410.04% in 2025.
  • Quarter analysis of 5 years shows BioCorRx's Current Assets stood at $228326.0 in 2021, then surged by 38.8% to $316910.0 in 2022, then tumbled by 40.96% to $187119.0 in 2023, then plummeted by 36.94% to $117996.0 in 2024, then skyrocketed by 1139.17% to $1.5 million in 2025.
  • Its Current Assets was $1.5 million in Q3 2025, compared to $527483.0 in Q2 2025 and $565796.0 in Q1 2025.